# Streptococcus Mutans Reduction Early Mother-infant Transmission

> **NCT04868513** · PHASE4 · COMPLETED · sponsor: **Biochemical and Microbiology Laboratory, Faculty of Dentistry, Autonomous University of San Luis Pot** · enrollment: 58 (actual)

## Conditions studied

- Pregnant Women

## Interventions

- **DRUG:** Pregnant women to whom applied silane fluoride
- **DRUG:** Pregnant women to whom applied silane fluoride + 1% chlorhexidine

## Key facts

- **NCT ID:** NCT04868513
- **Lead sponsor:** Biochemical and Microbiology Laboratory, Faculty of Dentistry, Autonomous University of San Luis Pot
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-10
- **Final completion:** 2017-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04868513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04868513, "Streptococcus Mutans Reduction Early Mother-infant Transmission". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04868513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*